APA (7th ed.) Citation

NA, V., A, S., WM, v. d. F., SD, M., C, M., CE, H., . . . R, V. (2008). Serum amyloid P component as a biomarker in mild cognitive impairment and Alzheimer's disease [corrected] [published erratum appears in DEMENT GERIATR COGNIT DISORD 2009;27(6): 584]. Dementia & Geriatric Cognitive Disorders, 26(6), 522. https://doi.org/10.1159/000178756

Chicago Style (17th ed.) Citation

NA, Verwey, Schuitemaker A, van der Flier WM, Mulder SD, Mulder C, Hack CE, Scheltens P, Blankenstein MA, and Veerhuis R. "Serum Amyloid P Component as a Biomarker in Mild Cognitive Impairment and Alzheimer's Disease [corrected] [published Erratum Appears in DEMENT GERIATR COGNIT DISORD 2009;27(6): 584]." Dementia & Geriatric Cognitive Disorders 26, no. 6 (2008): 522. https://doi.org/10.1159/000178756.

MLA (9th ed.) Citation

NA, Verwey, et al. "Serum Amyloid P Component as a Biomarker in Mild Cognitive Impairment and Alzheimer's Disease [corrected] [published Erratum Appears in DEMENT GERIATR COGNIT DISORD 2009;27(6): 584]." Dementia & Geriatric Cognitive Disorders, vol. 26, no. 6, 2008, p. 522, https://doi.org/10.1159/000178756.